Contact & Locations

Hemel Hempstead, UK

Consort Medical plc
Suite B
Breakspear Park
Breakspear Way
Hemel Hempstead
Tel: +44 (0) 1442 867 920
Fax:+44 (0) 1442 245 237

Hemel Hempstead is the Head Office for the Group.

Cambridge, UK

Bespak Europe Limited (Innovation Centre)
6-7 Technopark
Newmarket Road
Tel: +44 (0)1553 691 000

Site capabilities:

1,000m² site
600 m² of development labs and assembly space
Authority approvals include:

ISO 13485
ISO 14001

Cramlington, UK

Aesica Pharmaceuticals Limited
Windmill Industrial Estate
Shotton Lane
NE23 3JL
United Kingdom
Tel: +44 (0)1670 590595
Fax: +44 (0)1670 597360

Our Cramlington site has over 25 years’ experience in the manufacturing of APIs and we are experts in process scale up and technology transfer with a focus on safety, quality and regulatory compliance.

Multi-purpose site for:

Development capabilities
Pilot scale
Commercial scale plants
Generic API supply
Potent drugs and controlled substances
Authority approvals include:

MHRA, FDA, ISO 14001, ISO 9001, possession of controlled drugs and manufacture of controlled drugs.

King’s Lynn, UK

Bespak Europe Limited
Bergen Way
King’s Lynn
PE30 2JJ

Tel: +44 (0)1553 691 000

Site Capabilities

60,000m² site
26,790m² of manufacturing space
17,359m² of clean rooms
30 fully automated assembly suites
125 injection moulding machines
Authority approvals include:

ISO 13485
ISO 14001
Environmental Permit to Operate
MHRA commercial drug handling license

Lancashire, UK

Integrated Aluminium Components IAC
Edward Street

Tel: +44 (0)1282 699 921

Authority approvals include:

ISO 9001
ISO 14001
Environmental Permit to Operate

Milton Keynes, UK

Bespak Europe Ltd
Blackhill Drive
Milton Keynes
MK12 5TS

Tel: +44 (0) 1553 691000

Authority approvals include:

ISO 13485
ISO 14001

Queenborough, UK

Aesica Queenborough Limited
North Road
ME11 5EL
United Kingdom
Tel: +44 (0)1795 543000
Fax: +44 (0)1795 543335

Queenborough offers both finished dose and API services and has successfully expanded the customer portfolio and offers a broad technology portfolio.

  • Multi-purpose site offering:
  • 3 billion+ Tablet capacity capacity
  • 1.5 Million litres of liquid capacity
  • 98 bulk products
  • 12 APIs
  • API manufacturing services
  • Liquids and solid dose manufacturing and packaging
  • Blisters, bottles (solid dose, granules, oral liquids, anaesthetics), sachets
  • Analytical and development capabilities
  • Potent drug capability for manufacturing and packaging (Liquids/solids)
  • Controlled drug manufacturing and packaging
  • Continuous manufacturing technology
  • Storage capabilities including cold and controlled drug
  • Stand alone Development facility
  • Formulation development for oral, liquid, topical and inhaled products
  • Analytical method development
  • ICH stability testing
  • Clinical trial manufacture Phase I-III clinical manufacturing capability and QP release
  • Specialists in cytotoxics, high potency and controlled drugs
  • Embraces newer technologies.

Authority approvals include:
MHRA, EU, FDA, Korean FDA, PMDA, ANVISA, ROW, QP release, possession of controlled drugs and manufacture of controlled drugs.

Monheim, Germany

Aesica Pharmaceuticals GmbH
Alfred-Nobel- Straße 10
40789 Monheim
Tel: +49 2173 335 0
Fax: +49 2173 335 1020

Integrated packaging and distribution capabilities for blisters, bottles, sachets and pouches and artwork services.

Packaging site for:

  • A broad range of dose forms including syringes and pouches
  • Over 200 products/1500+ SKUs
  • Bulk importation and EU release testing
  • Multi country packaging and repackaging services
  • Analytical development
  • Artwork services
  • Stability with all ICH zones
  • QP release of final products to market
  • Distribution and logistics

Authority approvals include:

EU, FDA, Korean FDA, ANVISA, ROW, Gulf Country Council and QP release

Zwickau, Germany

Aesica Pharmaceuticals GmbH
Galileistraße 6
08056 Zwickau
Tel: 49 375 322 0
Fax: +49 375 322 585

Bulk production site excelling in solid dosage forms and offering a full spectrum of analytical and development capabilities.

Multi-purpose site for:

  • 3 billion+ capacity
  • 98 bulk products
  • 12 APIs
  • Pellet production
  • Hard gelatine capsules
  • Analytical and development capabilities

Authority approvals include:

EU, FDA, Korean FDA, PDMA, ANVISA, ROW, Gulf Country Council and QP release

Pianezza, Italy

Aesica Pharmaceuticals S.r.I.
Sede legale: Via Praglia,15
10044 Pianezza (TO)
Tel: +39 011 9660 1
Fax: +39 011 9660 244

Commercial scale manufacture of liquid products: both terminally sterilised injectables (vials and ampoules) and oral liquids. Blister packaging with fully automated flexible packaging lines and analytical capabilities.

Multi-purpose site for:

  • Manufacturing: injectables and oral liquid finished dose forms
  • Packaging: oral solid, oral liquid and injectable forms
  • Analytical capabilities and QP release

Authority approvals include:

EU, PMDA, AIFA, ANVISA, ROW, QP release, ISO 14001and ISO 9001